Role of interstitium in clearance of alveolar fluid in normal and injured lungs.
We investigated the contribution of the pulmonary interstitial space to the removal of alveolar fluid and solute. We prepared anesthetized sheep for the collection of lung lymph. A balloon-tipped catheter was advanced into a lower lung lobe, and 20 ml Ringer lactate solution (RL) were instilled in one group. Other groups received 20 ml RL with 4 mg/ml Evans blue dye (EB) or 10 micrograms/kg phorbol myristate acetate (PMA) or both. Instillation of 20 ml RL and EB resulted in an increase in lymph flow over RL alone, presumably by an osmotic mechanism. After 4 h, small perivascular fluid cuffs, which contained little EB, were present, and 1.9% of the instilled EB was removed by the lymphatics. An average of 9.2 ml of excess water remained in the lung. Instillation of RL, EB, and PMA resulted in an increase in lymph flow and large perivascular fluid cuffs, which contained large amounts of EB. Lymphatic removal of the instilled EB accounted for 1.2% of the total amount instilled. An average of 19.1 ml water was present in the lung after 4 h. We conclude that alveolar instillation of PMA results in epithelial and endothelial membrane injury and that when lung injury is present interstitial fluid reservoirs may be important sites of alveolar fluid accumulation and important routes of fluid removal from the air space.
D000042:Absorption; D000818:Animals; D001391:Azo Compounds / Q000378:metabolism*; D002199:Capillary Permeability; D002463:Cell Membrane Permeability; D005070:Evans Blue / Q000378:metabolism*; D005110:Extracellular Space / Q000378:metabolism*; D006439:Hemodynamics; D007552:Isotonic Solutions / Q000378:metabolism*; D008168:Lung / Q000502:physiology*; D008208:Lymphatic System / Q000502:physiology; D010704:Phorbols / Q000633:toxicity*; D011650:Pulmonary Alveoli / Q000502:physiology; D011654:Pulmonary Edema / Q000139:chemically induced / Q000503:physiopathology; D000077325:Ringer's Lactate; D012756:Sheep; D012996:Solutions; D013755:Tetradecanoylphorbol Acetate / Q000378:metabolism / Q000633:toxicity*
D001391:Azo Compounds; D007552:Isotonic Solutions; D010704:Phorbols; D000077325:Ringer's Lactate; D012996:Solutions; D005070:Evans Blue; D013755:Tetradecanoylphorbol Acetate